샘플 요청 목록

 카트 문의
시장보고서
상품코드
1584127

암 치료용 유전체학 시장 : 검사 유형별, 기술 유형별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Genomics in Cancer Care Market, By Test Type, By Technology Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 284 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

암 치료용 유전체학 시장 규모는 2023년에 181억 2,032만 달러에 달하며, 2024-2032년 16.10%의 CAGR로 확대

암 치료용 유전체학 시장 - 시장 역학

맞춤형 의료 중시의 증가가 암의료에서 게놈 시장을 촉진

맞춤형 의료에 대한 관심이 높아지면서 암 치료용 유전체학 시장이 크게 성장하고 있습니다. 미국 국립암연구소(NCI)의 연구 결과에 따르면 유전체 프로파일링에 기반한 맞춤 치료가 암 환자의 30% 이상에서 환자 예후를 개선할 수 있는 것으로 나타났습니다. 미국임상종양학회(ASCO)와 같은 단체는 치료 의사결정에 유전체 데이터를 통합하여 종양내 유전자 변이를 표적으로 하는 정밀 치료법 개발을 추진하고 있습니다. 또한 미국 국립보건원의 All of Us 연구 프로그램과 같은 대규모 구상은 유전적 요인이 암과 치료 효과에 미치는 영향을 더 잘 이해하기 위해 다양한 집단에서 광범위한 유전체 데이터를 수집하는 것을 목표로 하고 있습니다. 그 결과, 맞춤형 의료는 개념에서 실천으로 옮겨가고 있으며, 개별 환자에게 가장 효과적인 치료법을 찾기 위해 임상에서 게놈 검사를 점점 더 많이 채택하고 있습니다.

암 치료용 유전체학 시장 - 주요 인사이트

당사의 리서치 분석가들의 분석에 따르면 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 16.10%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

검사 유형별로는 생식세포 계열 게놈 검사가 22023년 가장 높은 시장 점유율을 차지했습니다.

기술 유형별로는 차세대 염기서열 분석(NGS)이 2023년 주요 유형으로 꼽혔습니다.

용도별로는 2023년 맞춤형 의료가 주요 유형으로 꼽혔습니다.

지역별로는 북미가 2023년 매출 1위

암 치료용 유전체학 시장 - 세분화 분석 :

암 치료에서 유전체학 세계 시장은 검사 유형, 기술 유형, 애플리케이션, 최종사용자 및 지역에 따라 세분화됩니다.

시장은 검사 유형에 따라 생식세포 게놈 검사와 체세포 게놈 검사의 두 가지 범주로 나뉩니다. 생식세포 계통 게놈 검사는 유전성 암 위험을 식별하고 예방 전략에 대한 정보를 제공하는 데 중요한 역할을 하므로 가장 높은 순위를 차지합니다. 체세포유전체검사는 종양 특이적 돌연변이에 초점을 맞추고 암 치료에서 개인 맞춤형 치료 옵션에 필수적인 지식을 제공하므로 그 뒤를 잇습니다.

시장은 기술 유형에 따라 차세대 시퀀서, PCR, 마이크로어레이, CRISPR, 차세대 시퀀서, PCR, 마이크로어레이, CRISPR의 네 가지 범주로 분류됩니다. 차세대 시퀀싱(NGS)은 방대한 양의 유전체 데이터를 효율적으로 분석할 수 있다는 점에서 가장 우선순위가 높으며, PCR이 그 뒤를 이어 표적 증폭에 널리 사용되고 있습니다. 마이크로어레이 기술은 3위를 차지했으며, CRISPR은 혁신적이지만 임상 적용은 아직 초기 단계에 있습니다.

암 치료용 유전체학 시장 - 지역적 인사이트

북미는 첨단 의료 인프라와 연구개발에 대한 막대한 투자로 암 치료에서 유전체학 시장을 독점하고 있습니다. 미국 국립암연구소는 게놈 검사가 암 환자의 약 50%를 치료하는 데 있으며, 게놈 검사가 지침이 될 것이라고 보고하고 있으며, 이는 정밀의료에서 유전체학의 중요한 역할을 강조하고 있습니다. 독일과 영국과 같은 국가들은 5백만 명 이상의 환자를 대상으로 일상적인 암 치료에 게놈 검사를 통합하는 것을 목표로 하는 유전체 영국 국민보건서비스(NHS) 프로젝트와 같은 강력한 유전체 의료 구상을 시행하고 있습니다. 아시아태평양에서는 중국, 일본과 같은 국가들이 유전체 기술을 빠르게 도입하고 있습니다. 중국의 13차 5개년 계획은 생명공학 발전에 중점을 두고 있으며, 유전체 연구와 응용에 대한 투자를 늘릴 계획입니다. 라틴아메리카에서는 게놈 검사에 대한 접근성이 점차 개선되고 있으며, 브라질 보건부는 암 치료 가이드라인에 유전체학을 도입하기 위한 노력을 추진하고 있습니다. 한편, 중동 및 아프리카에서는 유전체 의료를 지원하는 의료 인프라를 강화하는 데 주력하고 있으며, 이는 혁신적인 유전체 접근법을 통해 암에 대한 접근성을 높이고자 하는 의지를 반영하고 있습니다.

암 치료용 유전체학 시장 - 경쟁 구도 :

암 치료 유전체학 시장 경쟁 구도는 주로 북미가 주도하고 있으며, Illumina와 Thermo Fisher Scientific과 같은 주요 기업이 기술 혁신을 주도하고 있습니다. 암 진단 및 연구를 위한 유전체 시퀀싱 기능을 대폭 강화했습니다. 유럽에서 로슈는 강력한 경쟁자이며, 다양한 의료 기관과 적극적으로 협력하여 게놈 검사를 임상 진료에 통합하여 환자 결과를 개선하고 있습니다. 로슈와 Genomics England Initiative와의 파트너십은 10만 명의 암 환자의 유전체 데이터를 분석하여 개인 맞춤형 치료 전략의 길을 여는 것을 목표로 하고 있습니다. 한편, 아시아태평양에서는 BGI 그룹이 대규모 유전체 연구를 촉진하는 DNBSEQ 플랫폼을 개발하여 괄목할 만한 진전을 이루고 있습니다. 또한 일루미나가 그라일(Grail)을 인수함으로써 진단 정확도를 높이기 위해 액체생검 기술을 활용하여 조기 암 진단 시장에서의 입지를 강화하고 있습니다. 이러한 경쟁 환경은 유전체의 진보를 활용해 전 세계 암 치료에 혁명을 일으키겠다는 의지를 보여주며, 공동 연구와 혁신이 종양학의 미래를 형성하고 있습니다.

목차

제1장 암 치료용 유전체학 시장 개요

  • 조사 범위
  • 시장 추정년

제2장 개요

  • 시장 내역
  • 경쟁 인사이트

제3장 암 치료용 유전체학의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 향후 동향

제4장 암 치료용 유전체학 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 지도제작
  • 규제 구조 분석

제5장 암 치료용 유전체학 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 암 치료용 유전체학 시장 구도

  • 암 치료용 유전체학 시장 점유율 분석, 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업의 분석
    • 신규 기업의 분석

제7장 암 치료용 유전체학 - 검사 유형별

  • 개요
    • 검사 유형별 부문 점유율 분석
    • 생식 세포 게놈 검사
    • 체세포 게놈 검사

제8장 암 치료용 유전체학 - 기술 유형별

  • 개요
    • 기술 유형별 부문 점유율 분석
    • 차세대 시퀀싱(NGS)
    • PCR
    • 마이크로어레이
    • CRISPR

제9장 암 치료용 유전체학 - 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 바이오마커 발견
    • 맞춤형 의료
    • 의약품 발견과 개발
    • 임상 진단

제10장 암 치료용 유전체학 - 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 병원
    • 진단 검사실
    • 조사기관
    • 제약·바이오테크놀러지 기업

제11장 암 치료용 유전체학 - 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 - 암 치료용 유전체학

  • 경쟁 대시보드
  • 기업 개요
    • Adaptive Biotechnologies Corporation
    • Agilent Technologies, Inc.
    • BGI Group
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche AG
    • Foundation Medicine, Inc.(Roche)
    • Genomic Health, Inc.(Exact Sciences)
    • Guardant Health, Inc.
    • Illumina, Inc.
    • Myriad Genetics, Inc.
    • NeoGenomics, Inc.
    • Oxford Nanopore Technologies Ltd.
    • Pacific Biosciences of California, Inc.
    • PerkinElmer, Inc.
    • Qiagen NV
    • Thermo Fisher Scientific Inc.
    • Others

제13장 애널리스트의 전방위 전망

KSA 24.11.14

REPORT HIGHLIGHT

Genomics in Cancer Care Market size was valued at USD 18,120.32 Million in 2023, expanding at a CAGR of 16.10% from 2024 to 2032.

The Genomics in Cancer Care Market encompasses the application of genomic technologies to enhance cancer diagnosis, treatment, and prevention strategies. With the increasing understanding of the genetic basis of cancer, there is a growing emphasis on personalized medicine, which has led to significant advancements in genomics. A report from the National Cancer Institute indicated that genomic testing could improve treatment outcomes for over 40% of cancer patients by identifying specific mutations. The rising prevalence of cancer globally, coupled with the growing demand for precision therapies, is boosting market growth. However, challenges such as high costs associated with genomic testing and a lack of standardized guidelines may restrain widespread adoption. Additionally, ethical concerns surrounding genetic data usage present barriers to market expansion. Opportunities are emerging in the development of innovative genomic technologies, such as liquid biopsies and next-generation sequencing, which are transforming cancer diagnostics and treatment approaches. These advancements are expected to enhance patient outcomes and drive the future of cancer care.

Genomics in Cancer Care Market- Market Dynamics

Growing Emphasis on Personalized Medicine Propels the Genomics in Cancer Care Market

The growing emphasis on personalized medicine is significantly propelling the Genomics in Cancer Care Market, as evidenced by the National Cancer Institute's findings that tailored treatments based on genomic profiling can improve patient outcomes in over 30% of cancer cases. Organizations like the American Society of Clinical Oncology (ASCO) advocate for the integration of genomic data in treatment decision-making, promoting the development of precision therapies that specifically target genetic mutations in tumors. Additionally, large-scale initiatives, such as the All of Us Research Program by the National Institutes of Health, aim to gather extensive genomic data from diverse populations to better understand how genetic factors influence cancer and treatment efficacy. As a result, personalized medicine is transitioning from concept to practice, with genomic tests being increasingly adopted in clinical settings to identify the most effective treatments for individual patients, ultimately leading to better management of cancer care and improved survival rates.

Genomics in Cancer Care Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.10% over the forecast period (2024-2032)

Based on Test Type segmentation, Germline genomics testing was predicted to show maximum market share in the year 2023

Based on Technology Type segmentation, Next-Generation Sequencing (NGS) was the leading type in 2023

Based on Application segmentation, Personalized Medicine was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Genomics in Cancer Care Market- Segmentation Analysis:

The Global Genomics in Cancer Care Market is segmented on the basis of Test Type, Technology Type, Application, End-User, and Region.

The market is divided into two categories based on Test Type: Germline Genomics Testing, and Somatic Genomics Testing. Germline genomics testing ranks highest due to its critical role in identifying hereditary cancer risks and informing prevention strategies. Somatic genomics testing follows as it focuses on tumor-specific mutations, providing essential insights for personalized treatment options in cancer care.

The market is divided into four categories based on Technology Type: Next-Generation Sequencing, PCR, Microarray, and CRISPR. Next-Generation Sequencing (NGS) holds the highest priority due to its ability to analyze vast amounts of genomic data efficiently. PCR follows, widely used for targeted amplification. Microarray technology ranks third, while CRISPR, although innovative, is still emerging in clinical applications.

Genomics in Cancer Care Market- Geographical Insights

North America dominates the Genomics in Cancer Care Market, driven by advanced healthcare infrastructure and significant investments in research and development. The U.S. National Cancer Institute reported that genomic testing could guide treatment for nearly 50% of cancer patients, highlighting its critical role in precision medicine. Europe follows closely, with countries like Germany and the UK implementing robust genomic medicine initiatives, such as the Genomic UK National Health Service (NHS) project, aiming to integrate genomic testing into routine cancer care for over 5 million patients. In the Asia-Pacific region, countries like China and Japan are rapidly adopting genomic technologies; China's 13th Five-Year Plan emphasizes the development of biotechnology, with plans to increase investment in genomic research and application. Latin America is gradually improving access to genomic testing, with Brazil's Ministry of Health promoting initiatives to incorporate genomics into cancer treatment guidelines. Meanwhile, the Middle East & Africa are focusing on enhancing healthcare infrastructure to support genomic medicine, reflecting a growing commitment to tackling cancer through innovative genomic approaches.

Genomics in Cancer Care Market- Competitive Landscape:

The competitive landscape of the Genomics in Cancer Care Market is primarily led by North America, with key players like Illumina and Thermo Fisher Scientific driving innovation. In 2023, Illumina launched its Illumina NextSeq 2000 system, which significantly enhances genomic sequencing capabilities for cancer diagnostics and research. In Europe, Roche is a formidable competitor, actively collaborating with various healthcare institutions to integrate genomic testing into clinical practices, thus improving patient outcomes. Roche's partnership with the Genomics England initiative aims to analyze genomic data from 100,000 cancer patients, paving the way for personalized treatment strategies. Meanwhile, in the Asia-Pacific region, BGI Group is making notable advancements, having developed the DNBSEQ platform to facilitate large-scale genomic studies. Additionally, the acquisition of Grail by Illumina has reinforced its position in the early cancer detection market, utilizing liquid biopsy technology to enhance diagnostic precision. This competitive environment showcases a commitment to leveraging genomic advancements to revolutionize cancer care globally, with collaborations and innovations shaping the future of oncology.

Recent Developments:

In September 2024, The Indian Cancer Genome Atlas (ICGA) recently launched a multi-omics data portal for cancer, which is the first of its kind in India. The portal provides access to data on breast cancer patients, including their DNA, RNA, and protein profiles, treatment histories, and patient outcomes. The ICGA's goal is to create datasets specific to India to help researchers and clinicians develop personalized cancer treatments.

In September 2024, The UK's first robotic genomic testing facility was launched at The Royal Marsden NHS Foundation Trust, enhancing cancer patient care. This automation will double testing capacity, streamline processes, and improve access to personalized treatments by identifying genetic risks and mutations.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENOMICS IN CANCER CARE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Adaptive Biotechnologies Corporation
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Foundation Medicine, Inc. (Roche)
  • Genomic Health, Inc. (Exact Sciences)
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • NeoGenomics, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL GENOMICS IN CANCER CARE MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Germline Genomics Testing
  • Somatic Genomics Testing

GLOBAL GENOMICS IN CANCER CARE MARKET, BY TECHNOLOGY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Next-Generation Sequencing (NGS)
  • PCR
  • Microarray
  • CRISPR

GLOBAL GENOMICS IN CANCER CARE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Biomarker Discovery
  • Personalized Medicine
  • Drug Discovery & Development
  • Clinical Diagnostics

GLOBAL GENOMICS IN CANCER CARE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical & Biotechnology Companies

GLOBAL GENOMICS IN CANCER CARE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Genomics in Cancer Care Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Genomics in Cancer Care Market Snippet by Test Type
    • 2.1.2. Genomics in Cancer Care Market Snippet by Technology Type
    • 2.1.3. Genomics in Cancer Care Market Snippet by Application
    • 2.1.4. Genomics in Cancer Care Market Snippet by End-User
    • 2.1.5. Genomics in Cancer Care Market Snippet by Country
    • 2.1.6. Genomics in Cancer Care Market Snippet by Region
  • 2.2. Competitive Insights

3. Genomics in Cancer Care Key Market Trends

  • 3.1. Genomics in Cancer Care Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Genomics in Cancer Care Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Genomics in Cancer Care Market Opportunities
  • 3.4. Genomics in Cancer Care Market Future Trends

4. Genomics in Cancer Care Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Genomics in Cancer Care Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Genomics in Cancer Care Market Landscape

  • 6.1. Genomics in Cancer Care Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Genomics in Cancer Care Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2. Germline Genomics Testing
    • 7.1.3. Somatic Genomics Testing

8. Genomics in Cancer Care Market - By Technology Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology Type, 2023 & 2032 (%)
    • 8.1.2. Next-Generation Sequencing (NGS)
    • 8.1.3. PCR
    • 8.1.4. Microarray
    • 8.1.5. CRISPR

9. Genomics in Cancer Care Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Biomarker Discovery
    • 9.1.3. Personalized Medicine
    • 9.1.4. Drug Discovery & Development
    • 9.1.5. Clinical Diagnostics

10. Genomics in Cancer Care Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Research Institutes
    • 10.1.5. Pharmaceutical & Biotechnology Companies

11. Genomics in Cancer Care Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Genomics in Cancer Care Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Genomics in Cancer Care Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Genomics in Cancer Care Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Genomics in Cancer Care Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Genomics in Cancer Care Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Genomics in Cancer Care Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Adaptive Biotechnologies Corporation
    • 12.2.2. Agilent Technologies, Inc.
    • 12.2.3. BGI Group
    • 12.2.4. Bio-Rad Laboratories, Inc.
    • 12.2.5. F. Hoffmann-La Roche AG
    • 12.2.6. Foundation Medicine, Inc. (Roche)
    • 12.2.7. Genomic Health, Inc. (Exact Sciences)
    • 12.2.8. Guardant Health, Inc.
    • 12.2.9. Illumina, Inc.
    • 12.2.10. Myriad Genetics, Inc.
    • 12.2.11. NeoGenomics, Inc.
    • 12.2.12. Oxford Nanopore Technologies Ltd.
    • 12.2.13. Pacific Biosciences of California, Inc.
    • 12.2.14. PerkinElmer, Inc.
    • 12.2.15. Qiagen N.V.
    • 12.2.16. Thermo Fisher Scientific Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제